Kura Oncology, Inc.
Public company- Headquarters
- SAN DIEGO, California
- Ticker
- KURA
- CIK
- 0001422143
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CFOJennifer Fulk | Sep 8, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ACADIA PHARMACEUTICALS INC
Executive Vice President, Head of Research and Development departs: Elizabeth H.Z. Thompson, Ph.D.
- KYNTRA BIO, INC.
Class III director appointed: Andrew E. Singer, MBA
- BIOMARIN PHARMACEUTICAL INC
WARN notice: Novato, CA
- CORCEPT THERAPEUTICS INC
President of Corcept Endocrinology departs: Sean Maduck
- Executive appointment
CFO appointed: Jennifer Fulk
Jennifer Fulk was named Chief Financial Officer of Kura Oncology, Inc., effective September 8, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 8, 2026Role: Chief Financial Officer
Only one public record so far. We add events as soon as a new filing lands; watch Kura Oncology, Inc. to get them in your digest.
Last verified Nov 8, 2026